Log in
Propedeutics · Additional topics

Chronic kidney disease

Morbus renalis chronicus

Chronic kidney disease (CKD) is a progressive condition requiring precise staging to assess organ function. The key parameter determining the severity of the pathological process and patient management is the glomerular filtration rate.

Main markerGlomerular filtration rate (GFR)
Units of measurementmL/min/1.73 m²
Diabetes therapyDose selection depends on current GFR
CodingICD-10: N18.1 — N18.9
3 min readFor medical studentsUpdated 10.10.2026
Material prepared by WhiteCoat Pro editorial team based on platform study guidesPending instructor review

Basic terms and abbreviations

The following standardized abbreviations are regularly used in clinical practice and medical documentation related to nephrology and concomitant cardiac pathology:

  • CKD — chronic kidney disease.
  • eGFR — estimated glomerular filtration rate. This is a key calculated parameter reflecting the volume of plasma cleared by the kidneys per minute.
  • PCI — percutaneous coronary intervention. Frequently mentioned in the context of comorbid patients with cardiorenal syndrome.
  • NSTE-ACS — non-ST-segment elevation acute coronary syndrome. Another related cardiac condition requiring special attention in concomitant renal impairment.

CKD classification by GFR level

The basis for determining the stage of chronic kidney disease is the glomerular filtration rate (GFR) measured in mL/min/1.73 m². Each stage corresponds to a specific code in the International Classification of Diseases, 10th Revision (ICD-10).

CKD stageGFR levelICD-10 codeOfficial name
G1>90N18.1Chronic kidney disease, stage 1
G260–89N18.2Chronic kidney disease, stage 2
G3a45–59N18.3Chronic kidney disease, stage 3
G3b30–44see noteChronic kidney disease, stage 3
G415–29N18.4Chronic kidney disease, stage 4
G5<15N18.5Chronic kidney disease, stage 5

Important coding nuances: If the patient's disease stage is not established or specified at the time of examination, the special code N18.9 (Chronic kidney disease, unspecified) is used in medical documentation.

Test your knowledgeTasks from the "Propaedeutics" course bank — get answers and explanations instantly.

Peculiarities of prescribing hypoglycemic drugs

Chronic kidney disease imposes severe limitations on the pharmacotherapy of concomitant diseases. Specifically, there is a strict rule when treating diabetes mellitus in patients with nephrological pathology:

When prescribing any hypoglycemic drugs, the attending physician must first take into account the current level of the glomerular filtration rate (GFR). The feasibility of using a specific medicinal product and its safe dosage, which avoids toxic effects on the kidneys, directly depend on this parameter.

How to memorize

To memorize ICD-10 codes for CKD, note the direct relationship: the digit after the decimal point in the code (N18.X) strictly corresponds to the stage number (from 1 to 5). The exception is stage 3, which is subdivided into "a" and "b".

Class and exam questions

Which parameter is decisive for staging chronic kidney disease?

The main criterion for distinguishing CKD stages is the glomerular filtration rate (GFR), measured in mL/min/1.73 m².

How to properly code an ICD-10 patient if the CKD stage is unknown?

For cases of chronic kidney disease with an unspecified stage, code N18.9 is applied.

What is the main condition to follow when prescribing diabetes therapy to a patient with CKD?

When choosing and prescribing hypoglycemic drugs, it is critically important to consider the estimated glomerular filtration rate (eGFR).

Which GFR level corresponds to the end-stage (fifth stage) of CKD?

Stage G5 is established when the glomerular filtration rate drops below 15 mL/min/1.73 m² (ICD-10 code — N18.5).

Something unclear? Ask the AIThe AI tutor has read the material on "Chronic kidney disease" and will explain it in simple terms.

What else to study on this topic

  • Formulas and methods for determining the estimated glomerular filtration rate (eGFR)
  • Clinical differences and management tactics for patients at stages G3a and G3b
  • Specifics of performing percutaneous coronary intervention (PCI) in patients with renal failure
  • Pharmacokinetic specifics of hypoglycemic drugs depending on the CKD stage
  • Management of patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) against the background of severe CKD

Master the entire topic in the "Propaedeutics" course

This is a summary. The course covers everything tested in classes and exams.

  • Full WhiteCoat Pro study guide on "Chronic kidney disease" and 3,152 other subject pages
  • Assignments and quizzes after every topic — just like in a colloquium
  • AI tutor answers questions on the topic anytime
  • 113 video lessons on the subject

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.